Cargando…

Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer

The conversion of tumor-promoting M2 macrophage phenotype to tumor-suppressing M1 macrophages is a promising therapeutic approach for cancer treatment. However, the tumor normally provides an abundance of M2 macrophage stimuli, which creates an M2 macrophage-dominant immunosuppressive microenvironme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yongmei, Zheng, Yuanlin, Zhu, Yan, Li, Hongyun, Zhu, Hongyan, Liu, Tianqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344780/ https://www.ncbi.nlm.nih.gov/pubmed/35918698 http://dx.doi.org/10.1186/s12951-022-01526-2

Ejemplares similares

M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
por: Zhao, Yongmei, et al.
Publicado: (2021)

Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma
por: Scheetz, Lindsay M., et al.
Publicado: (2020)

Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
por: Gao, Tong, et al.
Publicado: (2023)

Biomimetic doxorubicin/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia
por: Chen, Mo, et al.
Publicado: (2022)

Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer
por: Lv, Qijun, et al.
Publicado: (2020)

Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy
por: Heo, Min Beom, et al.
Publicado: (2015)

Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo
por: Wang, Ying, et al.
Publicado: (2021)

Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
por: Dong, Hang, et al.
Publicado: (2023)

Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
por: Zhu, Ren, et al.
Publicado: (2017)

Macrophage M2 polarization induced by exosomes from adipose-derived stem cells contributes to the exosomal proangiogenic effect on mouse ischemic hindlimb
por: Zhu, Dihan, et al.
Publicado: (2020)

Lung Tumor Cell-Derived Exosomes Promote M2 Macrophage Polarization
por: Pritchard, Alexandra, et al.
Publicado: (2020)

Edible Pueraria lobata-Derived Exosomes Promote M2 Macrophage Polarization
por: Wu, Jiaqi, et al.
Publicado: (2022)

Impact of docetaxel plus ramucirumab in a second‐line setting after chemoimmunotherapy in patients with non‐small‐cell lung cancer: A retrospective study
por: Ishida, Masaki, et al.
Publicado: (2021)

MAPK signaling regulates the efficacy of chemoimmunotherapy
por: Ghiringhelli, François
Publicado: (2022)

M1 macrophage‐derived exosomes promote autoimmune liver injury by transferring long noncoding RNA H19 to hepatocytes
por: Zhang, Yongting, et al.
Publicado: (2023)

Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrug
por: Song, Jinxiao, et al.
Publicado: (2023)

Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
por: Liu, Siyan, et al.
Publicado: (2022)

Exosomal IRF1-loaded rat adipose-derived stem cell sheet contributes to wound healing in the diabetic foot ulcers
por: Wu, Min, et al.
Publicado: (2023)

Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes−liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer
por: Huang, Haiqin, et al.
Publicado: (2021)

The Regulation of Exosome-Derived miRNA on Heterogeneity of Macrophages in Atherosclerotic Plaques
por: Li, Ximing, et al.
Publicado: (2020)

Thymoquinone-loaded mesenchymal stem cell-derived exosome as an efficient nano-system against breast cancer cells
por: Ebrahimian, Mahboubeh, et al.
Publicado: (2022)

Exosomes Derived From M2b Macrophages Attenuate DSS-Induced Colitis
por: Yang, Ruibing, et al.
Publicado: (2019)

Exosomes Derived From M2 Macrophages Facilitate Osteogenesis and Reduce Adipogenesis of BMSCs
por: Li, Ziyi, et al.
Publicado: (2021)

Exosomes derived from M2 macrophages induce angiogenesis to promote wound healing
por: Lyu, Leifeng, et al.
Publicado: (2022)

M2 macrophage-derived exosomes promote diabetic fracture healing by acting as an immunomodulator
por: Wang, Yili, et al.
Publicado: (2023)

Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel
por: Kharaziha, Pedram, et al.
Publicado: (2015)

MicroRNA-370 carried by M2 macrophage-derived exosomes alleviates asthma progression through inhibiting the FGF1/MAPK/STAT1 axis
por: Li, Chunlu, et al.
Publicado: (2021)

Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer Therapy
por: Zhang, Xueyan, et al.
Publicado: (2019)

Exosomes in atherosclerosis: Convergence on macrophages
por: Yang, Kaiying, et al.
Publicado: (2022)

Bioinformatics analysis of dysregulated microRNAs in exosomes from docetaxel-resistant and parental human breast cancer cells
por: Chen, Wei-Xian, et al.
Publicado: (2019)

Chemoimmunotherapy as long-term maintenance therapy for cancer
por: Egilmez, Nejat K., et al.
Publicado: (2012)

Complete response of metastatic gastric cancer to chemoimmunotherapy
por: Ina, Kenji, et al.
Publicado: (2017)

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
por: Wang, Tianqi, et al.
Publicado: (2021)

Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
por: Liu, Yusheng, et al.
Publicado: (2022)

Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
por: Jain, Ankit, et al.
Publicado: (2012)

Blockade of LINC01605-enriched exosome generation in M2 macrophages impairs M2 macrophage-induced proliferation, migration, and invasion of human dermal fibroblasts
por: Zhu, Zhensen, et al.
Publicado: (2021)

Adipose-Derived Mesenchymal Stem Cells Promote M2 Macrophage Phenotype through Exosomes
por: Heo, June Seok, et al.
Publicado: (2019)

M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer effect of gemcitabine
por: Tang, Zhiling, et al.
Publicado: (2022)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
por: Zheng, Naisheng, et al.
Publicado: (2023)

Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer
por: Peng, Yilin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8r7ilpenr30csofa9askpcsfdi